Development of an immune enhancing vaccine to protect Tasmanian devils against a contagious cancer

开发免疫增强疫苗以保护塔斯马尼亚恶魔免受传染性癌症的侵害

• 批准号: LP130100218
• 负责人: Prof Gregory Woods
• 金额: $ 29.66万
• 依托单位: University of Tasmania
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-03-31 至 2017-04-14
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP130100218
• 关键词: Development; immune; enhancing; vaccine; protect

The iconic Tasmanian devil is threatened with extinction from a uniformly fatal transmissible facial cancer. Our team has shown in proof of concept that the cancer cells can be recognised by the devil immune system. This project will develop and test a vaccine against the tumour, which will ultimately protect devils in the wild.

标志性的塔斯马尼亚魔鬼正面临灭绝的威胁，因为它患有一种致命的传染性面部癌症。我们的团队已经证明了癌细胞可以被魔鬼免疫系统识别。该项目将开发和测试一种针对肿瘤的疫苗，最终将保护野生魔鬼。